← All supplements

Ranked by evidence within the category

Joint and skin supplements: what the evidence says

This category covers 74 supplements for joints, bones, skin and hair, and none reaches a strong rating: 18 are moderate and 56 limited. The best-supported options are curcumin and boswellia for joint pain, collagen peptides for skin elasticity and hydration, and a handful of knee osteoarthritis options such as ASU and UC-II, though many of these trial bases are small or manufacturer-funded. Much of the rest, including glucosamine, biotin, MSM, hyaluronic acid and hair-skin-nails formulas, has limited evidence.

Evidence last reviewed: September 2026

Moderate evidence (18)

  • The active compound in turmeric, with anti-inflammatory action.

  • Hydrolyzed collagen protein.

  • Heavily studied and genuinely mixed: pooled analyses show a small pain benefit in knee osteoarthritis, but the effect shrinks as trial quality rises, and the largest independent trial was null.

  • Boswellia resin extracts modestly reduce knee osteoarthritis pain and stiffness in placebo-controlled trials, usually within 4 weeks.

  • Willow bark standardised to 240 mg salicin per day probably beats placebo for short-term low back pain, but the best-conducted osteoarthritis and rheumatoid arthritis trials were negative.

  • A 40 mg daily dose of undenatured type II collagen improved knee osteoarthritis symptoms more than placebo — and more than glucosamine plus chondroitin — in a 180-day randomised trial.

  • ASU at 300 mg/day meaningfully reduces pain and improves function in knee osteoarthritis across pooled placebo-controlled trials, but the same analyses show no benefit in hip OA.

  • Niacinamide (nicotinamide) is the non-flushing amide form of vitamin B3, and at 500 mg twice daily it cut new skin cancers by about 23% in high-risk immunocompetent patients.

  • Fish-derived type I collagen peptides perform about as well as bovine peptides for modest gains in skin hydration and elasticity — the format is legitimate, but the "marine is more bioavailable" marketing rests on molecular-weight arguments, not head-to-head human trials.

  • Gelatin is collagen peptides' cheaper, less processed sibling — the same amino acids at a fraction of the price, with the best single piece of connective-tissue evidence in the whole collagen category coming from a gelatin trial, not a branded peptide.

  • White peony root (Paeonia lactiflora) is unusual among herbs: its standardized extract, total glucosides of paeony (TGP), is an approved prescription immunomodulator in China with a real trial base in rheumatoid arthritis and other autoimmune conditions.

  • Green-lipped mussel extract has a genuine but modest and inconsistent evidence base in osteoarthritis — several small positive trials, several null ones, and persistent quality problems.

  • PEA is a naturally occurring fatty acid amide with a real, replicated analgesic signal in meta-analyses of chronic and neuropathic pain — larger than most supplements manage.

  • A bioavailable form of silicon with several small randomized trials on hair, nails, skin and bone markers.

  • Standardised powder from the fruit of Rosa canina, one of the better-tested herbal options for osteoarthritis pain.

  • Combinations of calcium, vitamin D, vitamin K2 and trace minerals.

  • Blends built around curcumin and boswellia for joint pain.

  • A minor whey fraction, dosed at only 40 mg a day, that raised bone mineral density in several small randomized trials in women.

Limited evidence (56)

  • A popular joint supplement — but the largest independent trial found no significant benefit over placebo for most people with knee osteoarthritis.

  • Biotin is sold everywhere for hair, skin and nails, and the evidence for that use in people without deficiency is close to nonexistent.

  • A cheap, remarkably safe sulfur compound with a handful of small, mostly positive joint pain trials — none large or rigorous enough to be convincing.

  • Oral hyaluronic acid has a modest, mostly favourable trial record for skin hydration and knee pain, but the studies are small, heavily concentrated in Japan, and usually funded by ingredient makers.

  • Borage oil is the richest common source of gamma-linolenic acid (GLA), roughly triple the concentration in evening primrose oil.

  • Sea buckthorn oil is nutritionally interesting — it is one of very few plant oils containing palmitoleic acid (omega-7) — but the human evidence is thin.

  • The "brain tonic" claims do not survive meta-analysis, which found no benefit in any cognitive domain.

  • Two small randomized trials from the early 2000s found modest pain relief in knee osteoarthritis and rheumatoid arthritis, and essentially nothing has confirmed them in the two decades since.

  • Bromelain, a pineapple-derived protease, shows modest anti-inflammatory and analgesic effects in small trials of osteoarthritis and post-surgical swelling, but the evidence base is fragmented, mostly low quality, and dominated by combination products.

  • Serrapeptase (serratiopeptidase) has a small, low-quality evidence base for reducing swelling and trismus after dental surgery, and essentially nothing supporting the sweeping claims about dissolving arterial plaque, scar tissue or mucus.

  • Devil's claw shows a real but small and low-confidence signal for short-term low back pain at 50-100 mg harpagoside per day.

  • Pooled trials show eggshell membrane produces small but statistically significant improvements in knee osteoarthritis pain and function at 500 mg/day.

  • Small manufacturer-run trials report modest gains in skin hydration after 6-12 weeks of oral plant-derived ceramides, but the studies are tiny, short and use soft endpoints.

  • Polypodium leucotomos extract raises the UV dose needed to redden skin and may reduce photodermatosis flares, but trials are small and short and the protection is weak — equivalent to a very low SPF.

  • Bamboo extract is the most concentrated natural silica source sold (up to 70% silica by weight), but that silica is largely insoluble phytolith silica with poor absorption — and the human hair/skin/nail trials everyone cites were run on a different, soluble form (choline-stabilized orthosilicic acid), not bamboo.

  • "Five types of collagen in one scoop" is a marketing construct, not a research finding — no trial has tested a multi-type blend head-to-head against a single-source peptide, and the type II and X fractions are usually present in token amounts.

  • These products contain no collagen — they are vitamin C, amino acids, silica and biotin sold as raw materials for your own collagen synthesis.

  • Oral keratin (usually solubilized wool keratin, sold as Cynatine HNS) rests on a single small manufacturer-funded trial; the intuitive idea that eating hair protein makes hair is not how protein digestion works.

  • These formulas are built around megadose biotin, which does nothing for hair in people who are not deficient — and which reliably corrupts common blood tests, including the troponin assay used to diagnose heart attacks.

  • Oregon grape cream has modest randomized evidence for mild-to-moderate plaque psoriasis, where it beats placebo but loses to standard prescription topicals.

  • Chinese skullcap (Scutellaria baicalensis) has one week-long trial for knee osteoarthritis using a proprietary blend, and a documented history of liver injury when its baicalin was sold as the medical food flavocoxid.

  • BPC-157 is an experimental peptide with impressive rat healing data, essentially no published human trials, and no legal status as a dietary supplement.

  • Squalene is a natural lipid your own skin makes and a well-validated vaccine adjuvant, but as an oral supplement it has almost no controlled human evidence.

  • Tremella fuciformis is marketed as a plant-based hyaluronic acid alternative for skin, but that claim rests on the polysaccharide's water-binding chemistry in a beaker, not on oral trials.

  • Oral homeopathic arnica pellets, taken for bruising and post-surgical swelling, have been tested repeatedly and the best-quality placebo-controlled trials are negative.

  • A waxy fatty acid ester marketed for arthritis since the 1990s on the strength of a handful of small, industry-linked trials that have never been independently replicated.

  • The best-tested version of this category — glucosamine plus chondroitin — failed its largest independent trial and its largest network meta-analysis.

  • An acetylated form of glucosamine promoted for joints and the gut lining.

  • A plant-style boron-carbohydrate complex studied mainly for knee discomfort.

  • A plant antioxidant used mainly to stabilise vitamin C and E in topical serums.

  • An Ayurvedic root (Rubia cordifolia) traditionally used as a blood purifier for skin complaints.

  • An Ayurvedic herb famous for hair growth and liver support.

  • The plant that gave aspirin its name, containing salicylate precursors.

  • Marigold flower extract with a modest evidence base for topical wound and skin care.

  • A marine animal rich in chondroitin-like glycosaminoglycans, sold for joint pain.

  • Ground pearl, used for centuries in Chinese medicine as a beauty tonic.

  • A popular anti-ageing supplement across parts of Asia.

  • A seed oil supplying gamma-linolenic acid, sold for dry skin and eczema.

  • An amino acid that makes up a large share of collagen, sold on that basis for skin and joints.

  • Fish-derived protein and mucopolysaccharide blends taken for thinning hair.

  • A hair supplement ingredient always paired with L-cystine, biotin and pantothenic acid.

  • Hydrolysed elastin from fish, marketed for skin elasticity by analogy with collagen peptides.

  • A proteoglycan extracted from salmon nasal cartilage, popular in Japan for joints and skin.

  • A ginger relative whose joint reputation comes from one large trial where it was combined with ginger.

  • A triterpene extract whose only well-tested use is a topical gel for wound healing in the rare skin disease epidermolysis bullosa.

  • A traditional East Asian and North American rhizome used for tendons and joints.

  • A saponin-rich desert root long sold for arthritis.

  • An Amazonian tree resin rich in beta-caryophyllene, marketed for inflammation and skin.

  • A concentrated cucumber extract sold for joint pain.

  • Capsules combining zinc, vitamin A and botanicals for acne-prone skin.

  • Oral glutathione, usually with vitamin C and other antioxidants, marketed for a lighter or more even complexion.

  • Enteric-coated proteases — serrapeptase, bromelain, trypsin — taken on an empty stomach for swelling and inflammation.

  • Dried cattle cartilage, sold as a whole-food source of collagen and glycosaminoglycans for joints.

  • A classical Ayurvedic decoction of ten roots, used traditionally for pain, inflammation and vata disorders.

  • A fern rhizome used in Chinese medicine for fractures and bone loss.

  • A root used in Chinese formulas for the knees and lower back, almost always as one component of a multi-herb prescription.

Comparison guides for this category

Goals these supplements are ranked for

Our verdict

For knee osteoarthritis pain, curcumin or boswellia are reasonable to try for a few weeks, and collagen peptides or plain gelatin are a fair bet for skin. Be sceptical of large effects reported only in single-manufacturer trials, and of beauty blends promising stronger hair and nails, which sit in the limited tier.